0000-0001-8719-5258 About
Dr. Hemant R Jadhav is presently working as a Professor, at the Department of Pharmacy, BITS Pilani, Pilani Campus. He received his Ph.D. degree in the year 2004 from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India. He has been involved in research for the last 24 years and in teaching for the last 20 years. His research area is Pharmaceutical Chemistry, particularly, the design, synthesis, and evaluation of anti-Alzheimers, anti-cancer, anti-HIV compounds, and compounds for diabetic cardiomyopathy. He has successfully completed several research projects sponsored by DST, UGC, and the industry. Presently, he has a SERB CRG, and an ICMR project as Principal Investigator and is a co-investigator in a DBT BUILDER project worth 9.2 crores. He has supervised seven Ph. D students, and seven students are pursuing Ph.D. under his guidance. He has authored more than 60 research papers and 3 book chapters, as well as his work is presented at more than 50 national and international conferences. He is a member of the Board of Studies, a member of the Academic Council, and an external DRC member of various Universities. He also is an expert reviewer of many national and international journals. At BITS Pilani, Pilani campus, he has served in various administrative positions such as Head of the department, Associate dean, Academic Research (Ph. D. Programme) division, and sponsored research and consultancy division for many years.
Employment
-
Birla Institute of Technology and Science, Pilani Professor
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (66)
- Butadiene Sulfone-catalyzed Monobromination of Arenes with NBS as the Bromination Source: A Simple, Mild, Efficient, and Chemoselective Protocol Save
- Bioactivity predictions and virtual screening using machine learning predictive model Save
- Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity Save
- Investigation of antibacterial potential of Natsiatum herpeticum Buch.-Ham. ex Arn. using in silico-in vitro approach Save
- Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents Save
- Design, Synthesis, and Pharmacological Evaluation of Embelin-Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood-Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448 Save
- Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors Save
- Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential Save
- FDA approved fused-pyrimidines as potential PI3K inhibitors: a computational repurposing approach Save
- Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure-Based Virtual Screening of FDA-approved Drugs Save